Is Archer Aviation Stock Going to $13 a Share?

Archer Aviation trades at $5.80, well below Canaccord’s $13 target and 57% under its lifetime high of $14.62, implying a 124% rally would be needed to hit the analyst target. The company remains on track for piloted operations and UAE commercial launches, but it posted a $618.2 million net loss last year and is likely to face further dilution as it funds production scaling. The article is constructive on long-term optionality, but near-term execution and financing risks dominate.

Analysis

ACHR is still trading like a pre-venue option on two binary events: a credible commercial launch and a clean capital-raising cycle. The market is underestimating how quickly unit economics can deteriorate once management shifts from prototype spending to real production; in hardware ramp stories, gross margin disappointment usually shows up before revenue inflects, so the first meaningful downside catalyst may be weaker-than-expected delivery cadence rather than a headline miss.

The bigger second-order winner may be JOBY, not because it is immune to sector sentiment, but because any investor comparison will increasingly center on execution quality, certification progress, and fleet readiness. If ACHR stumbles on launch timing or execution in the UAE/defense channel, capital is likely to rotate within the eVTOL basket toward the name perceived as the cleaner regulatory path. That relative-value spread could widen over the next 1-2 quarters even if both names trade directionally with risk appetite.

The article’s “public-sector deals” angle is the real convexity: defense and municipal partnerships matter more than initial consumer flights because they can validate procurement economics and reduce perceived commercialization risk. But that catalyst is highly lumpy and prone to hype leakage; if no contract headlines emerge by the next operating update, the stock likely re-rates toward cash-burn math and repeated dilution, which caps upside even if launch milestones are met.

Consensus is focused on whether ACHR can go higher; the more important question is whether the company can finance growth without destroying per-share value. With a multi-year runway at current burn, management has room to avoid distress, but not enough reason to be shareholder-friendly — equity issuance during any rally is the most likely path, which makes short-dated upside chase risky and favors selling strength rather than buying breakouts.

Key Decisions for Investors

• Fade rallies in ACHR with short-dated call spreads or outright short into launch/partnership hype; use 2-3 month horizons and target 20-30% downside if no new defense/public-sector catalyst appears.
• Pair trade: long JOBY / short ACHR for 1-2 quarters to express relative execution quality; thesis is certification and commercialization credibility outruns headline-driven sentiment.
• Buy ACHR on a post-dilution, post-news pullback only if launch milestones are confirmed; require a drawdown of 10-15% from local highs to improve entry risk/reward.
• If seeking convexity, prefer ACHR upside via calls only around binary catalyst windows; keep premium size small because dilution and execution risk make delta one exposure unattractive.
• Monitor for equity offering risk after any 15%+ move higher; if management taps the market, expect a fast 8-12% retracement and use that as a cleaner re-entry point or short cover.